Rennova Health, Inc. s in-depth stock price analysis indicates that the stock price has dropped -33.3% in the past 12 Weeks but analyzing the 6 month chart of the stock, the price of the stock has managed to drop negative and it has dropped down to -76.58% . Looking at the past 52 week period, the stock price is down -92.94% . Relative price strength is a important factor used by wealth management firms while investing in stocks since the indicator compares the stock performance with the overall market. The relative price strength of Rennova Health, Inc. has a negative value of -88.93 compared to overall market performance. Rennova Health, Inc. (NASDAQ:RNVA) has tumbled 12.28% during the past week and has dropped 37.58% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 12.99%. Rennova Health, Inc. (NASDAQ:RNVA) has underperformed the index by 38.7% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
Rennova Health, Inc. (NASDAQ:RNVA) stock ended Friday session in the red zone in a volatile trading. The stock closed down 0.0015 points or 2.47% at $0.0593 with 6,734,682 shares getting traded. Post opening the session at $0.06, the shares hit an intraday low of $0.0521 and an intraday high of $0.064 and the price was in this range throughout the day. The company has a market cap of $9 million and the number of outstanding shares has been calculated to be 151,982,610 shares. The 52-week high of Rennova Health, Inc. (NASDAQ:RNVA) is $1.16 and the 52-week low is $0.0466.
Company has reported several Insider transactions to the SEC, on Jul 19, 2016, Christopher Eric Diamantis (director) purchased 333,333 shares at 0.44 per share price.On Jul 19, 2016, Michael Louis Goldberg (director) purchased 2,500 shares at 0.28 per share price.On Jul 15, 2016, Llc Alcimede (CEO) purchased 10,900 shares at 0.58 per share price.
Rennova Health, Inc. provides diagnostics and supportive software solutions to healthcare providers. The Companys solutions include diagnostic solutions, revenue cycle management, healthcare software solutions, financial services, diagnostic laboratory testing and analytics for precision medicine, electronic health records and other software services. Rennova Health, Inc., formerly known as CollabRx, Inc., is headquartered in West Palm Beach, Florida.